| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 3 | |
| #2 | Canada | 2 | |
| #3 | EPO (European Patent Office) | 2 | |
| #4 | New Zealand | 2 | |
| #5 | WIPO (World Intellectual Property Organization) | 2 | |
| #6 | Australia | 1 | |
| #7 | China | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Sugars | |
| #4 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Harper Jacquie Lucille | 10 |
| #2 | Le Gros Graham Stephen | 8 |
| #3 | Severn Wayne Bruce | 7 |
| #4 | Beasley Charles Richard Willia | 4 |
| #5 | Atkinson Paul Henry | 3 |
| #6 | Holloway John William | 2 |
| #7 | Erb Klaus | 2 |
| #8 | Scanga Connie Black | 2 |
| #9 | Singh-Gill Gurmit | 2 |
| #10 | Jones Jeremy David | 2 |
| Publication | Filing date | Title |
|---|---|---|
| US2008249037A1 | Synthetic molecules having immune activity | |
| NZ505538A | A vaccine comprising immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide (PIM); and the use of PIM for inducing an immune response in a patient effective in the prevention or treatment of Th2-mediated diseases or disorders such as asthma | |
| NZ513823A | Treatment of asthma | |
| US6569436B1 | Method of using a vaccine |